Neurobiological Underpinnings of Placebo Response in Major Depressive Disorder

Have you been feeling down, depressed, or hopeless?

You may be eligible to participate in a research study at Massachusetts General Hospital.

We are studying the brain chemistry of people who get better taking an FDA approved antidepressant medication and people who get better taking a placebo.

You will receive FDA approved bupropion XL (Wellbutrin XL®) or placebo for 4 weeks to 8 weeks and undergo two positron emission tomography-magnetic resonance (PETMR) scans.

You will be compensated up to $832.

If you are interested in participating, please click here or contact Ashley Meyer at 617-643-2497 or AKMEYER@mgh.harvard.edu or at MGHNBPStudy@partners.org. All inquiries will be kept confidential.

< Back to Our studies listing